Table 5. Cox analysis of factors... | American Society of Hematology

Table 5.

Cox analysis of factors affecting outcome independently among patients alive and disease-free on day 120

Outcome	Covariate	Favorable	Adverse	Risk ratio, 95% CI (range)	P
Relapse	Disease risk	Standard	Intermediate	3.3 (1.1-9.8)	.034
			High	11.1 (3.5-35.1)	< .0001
	CR-transplantation interval	≥ 120 d	< 120 d	2.6 (1.1-6.2)	.031
	Maintenance therapy	2-3 agents	0-1 agent	2.7 (1.0-7.2)	.049
DFS	Disease risk	Standard	Intermediate	3.1 (1.2-7.9)	.018
			High	7.2 (2.5-20.6)	< .0001
	CR-transplantation interval	≥ 120 d	< 120 d	2.3 (1.0-5.1)	.038
	Maintenance therapy	2-3 agents	0-1 agent	2.5 (1.0-6.0)	.046
OS	Disease risk	Standard	Intermediate	3.0 (1.2-7.7)	.024
			High	3.5 (1.2-10.5)	.024
	Maintenance therapy	2-3 agents	0-1 agent	2.9 (1.2-7.1)	.022

Outcome	Covariate	Favorable	Adverse	Risk ratio, 95% CI (range)	P
Relapse	Disease risk	Standard	Intermediate	3.3 (1.1-9.8)	.034
			High	11.1 (3.5-35.1)	< .0001
	CR-transplantation interval	≥ 120 d	< 120 d	2.6 (1.1-6.2)	.031
	Maintenance therapy	2-3 agents	0-1 agent	2.7 (1.0-7.2)	.049
DFS	Disease risk	Standard	Intermediate	3.1 (1.2-7.9)	.018
			High	7.2 (2.5-20.6)	< .0001
	CR-transplantation interval	≥ 120 d	< 120 d	2.3 (1.0-5.1)	.038
	Maintenance therapy	2-3 agents	0-1 agent	2.5 (1.0-6.0)	.046
OS	Disease risk	Standard	Intermediate	3.0 (1.2-7.7)	.024
			High	3.5 (1.2-10.5)	.024
	Maintenance therapy	2-3 agents	0-1 agent	2.9 (1.2-7.1)	.022